Form 4: Praxis Precision Medicines Executive Sells Shares to Cover Tax Obligations

Alex Nemiroff, General Counsel and Secretary of Praxis Precision Medicines, sold 89 shares to cover tax obligations related to vesting restricted share units.

Summary

• Alex Nemiroff, the General Counsel and Secretary of Praxis Precision Medicines, sold 89 shares of common stock on January 7, 2025.
• The sale was executed to cover tax withholding obligations associated with the vesting of previously reported restricted share units.
• The shares were sold at a price of $77.52 per share.
• Following the transaction, Mr. Nemiroff directly owns 10,211.667 shares of Praxis Precision Medicines.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction for tax purposes, which is neither positive nor negative for the company's overall outlook. The sentiment is neutral to slightly positive as it indicates the executive is receiving equity compensation.

Industry Context

This is a routine transaction for executives who receive equity compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the industry.
• The number of shares sold is relatively small compared to the total holdings of the executive, which is typical for these types of transactions.
• The price of $77.52 per share is a reflection of the current market value of the stock at the time of the transaction.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a small sale by an executive to cover tax obligations.

Key Dates

Keywords

Praxis Precision Medicines, insider trading, Form 4, stock sale, executive, tax obligations, restricted share units, equity